Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torben Barington

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2024
Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Leukemia & Lymphoma|January 12, 2019
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE studyDaniele Campa, Alessandro Martino, Angelica Macauda, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 27, 2016
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis opticaPatrick Waters, Markus Reindl, Albert Saiz, et al.
International Journal of Cancer|March 6, 2021
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patientsAngelica Macauda, Chiara Piredda, Alyssa I Clay-Gilmour, et al.
International Journal of Cancer|September 9, 2022
A pleiotropic variant in DNAJB4 is associated with multiple myeloma riskMarco Dicanio, Matteo Giaccherini, Alyssa Clay-Gilmour, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2024
Correction: Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19Maria Ormhøj, Irene Scarfò, Maria L Cabral, et al.
Leukemia & Lymphoma|January 12, 2019
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE studyDaniele Campa, Alessandro Martino, Angelica Macauda, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 27, 2016
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis opticaPatrick Waters, Markus Reindl, Albert Saiz, et al.
International Journal of Cancer|March 6, 2021
Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patientsAngelica Macauda, Chiara Piredda, Alyssa I Clay-Gilmour, et al.
International Journal of Cancer|September 9, 2022
A pleiotropic variant in DNAJB4 is associated with multiple myeloma riskMarco Dicanio, Matteo Giaccherini, Alyssa Clay-Gilmour, et al.
Pageof 7